{"gene":"HBA1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1976,"finding":"The hexanucleotide sequence AAUAAA (encoded by the HBA1/HBA2 and HBB mRNAs, as well as other eukaryotic mRNAs) is located approximately 20 residues upstream of the 3'-terminal poly(A) sequence and is conserved across alpha- and beta-globin mRNAs of rabbit and human, establishing it as the canonical polyadenylation signal in eukaryotic mRNAs.","method":"RNA sequencing of purified mRNAs including human and rabbit alpha- and beta-globin mRNAs","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — direct sequencing of purified mRNAs; replicated across multiple globin mRNAs and species; foundational discovery cited >2900 times","pmids":["822353"],"is_preprint":false},{"year":1975,"finding":"Three-dimensional X-ray crystallographic refinement of human deoxyhaemoglobin at 2.5 Å resolution established the atomic model of the T-state (deoxy) quaternary structure of HbA, defining the spatial arrangement of the alpha (HBA1/HBA2) and beta subunits in the low-affinity conformation.","method":"X-ray crystallography, atomic model refinement","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure; foundational structural determination cited >380 times","pmids":["1177322"],"is_preprint":false},{"year":1983,"finding":"Crystal structure of human oxyhaemoglobin at 2.1 Å resolution revealed that the iron atom in the alpha subunit (HBA1/HBA2) is 0.16 Å from the porphyrin plane, the Fe–O bond length is 1.66 Å, and a hydrogen bond from the oxygen ligand to the distal HisE7 is present in the alpha subunit; the R-state (oxy) quaternary structure was confirmed, with the C-terminal ArgHC3(141α) unable to form T-state intersubunit salt bridges.","method":"Single crystal X-ray analysis, Jack-Levitt refinement","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with detailed active-site geometry; cited >500 times","pmids":["6644819"],"is_preprint":false},{"year":1980,"finding":"Nonenzymatic glycosylation of human haemoglobin A occurs at multiple specific lysine residues on both the alpha (HBA1) and beta chains; the alpha chain is glycosylated preferentially at LysA16(α16) and other surface lysines, establishing the molecular basis for HbA1c and related glycated haemoglobin species.","method":"In vitro glycosylation assay with [14C]-glucose followed by peptide mapping and sequencing of glycated peptides","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical identification of glycation sites by peptide mapping; cited >300 times","pmids":["7358733"],"is_preprint":false},{"year":1992,"finding":"Human haemoglobin adopts a third stable quaternary structure (R2-state) for liganded HbA at 1.7 Å resolution; in the R2-state the α1β2 interface 'switch' region (His97β) rotates away from Thr38α1 and Thr41α1, opening the interface and potentially functioning as a stable intermediate on an R→R2→T pathway during allosteric transition of the alpha (HBA1) and beta subunits.","method":"X-ray crystallography at 1.7 Å resolution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure revealing a novel quaternary state; cited >247 times","pmids":["1512262"],"is_preprint":false},{"year":1992,"finding":"A recombinant human haemoglobin with tandemly fused (di-alpha) alpha-globin subunits (encoded by HBA1) and a mutant beta-globin with reduced oxygen affinity was expressed in E. coli and shown to function as a blood substitute: fusion of the two alpha subunits prevented dissociation into αβ dimers (increasing in vivo half-life and eliminating renal toxicity) and the beta mutation restored physiologically appropriate oxygen unloading.","method":"Recombinant protein expression in E. coli, in vitro oxygen affinity measurements, in vivo pharmacokinetic studies","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and functional validation; cited >249 times","pmids":["1552945"],"is_preprint":false},{"year":2006,"finding":"Crystal structures of human haemoglobin in oxy, deoxy, and carbonmonoxy forms refined to 1.25 Å resolution clarified that the distal histidine (HisE7) forms a hydrogen bond to the oxygen ligand in both the alpha (HBA1) and beta subunits in the R-state, and revealed subtle geometric differences in the hydrogen-bond geometry between subunits that explain differential phenotypes when HisE7 is mutated in alpha versus beta globin.","method":"High-resolution X-ray crystallography (1.25 Å) for three liganded states","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — highest-resolution crystal structures of all three ligation states; cited >235 times","pmids":["16765986"],"is_preprint":false},{"year":2012,"finding":"Haemoglobin alpha (encoded by HBA1/HBA2) is expressed in arterial endothelial cells and is enriched at the myoendothelial junction, where it regulates nitric oxide (NO) signalling: Hb α in the Fe(3+) (met) state permits eNOS-derived NO to reach vascular smooth muscle, whereas reduction to Fe(2+) by endothelial cytochrome b5 reductase 3 (CYB5R3) quenches NO bioactivity. Genetic depletion of Hb α or pharmacological inhibition of CYB5R3 altered vascular reactivity in small arteries.","method":"Co-immunoprecipitation, subcellular fractionation/immunofluorescence localization, genetic knockdown (siRNA/knockout mice), pharmacological inhibition, ex vivo vascular reactivity assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (localization, KO phenotype, pharmacological rescue) in a single study; cited >272 times","pmids":["23123858"],"is_preprint":false},{"year":1990,"finding":"A terminal truncation of chromosome 16p13.3 to a site 50 kb distal to the alpha-globin gene cluster (causing alpha-thalassaemia) was stabilized by direct addition of telomeric (TTAGGG)n repeats to the break site, demonstrating that telomeric DNA alone is sufficient to cap and stabilize a broken chromosome end; this also defined the chromosomal context essential for normal HBA1 expression.","method":"Southern blotting, pulsed-field gel electrophoresis, DNA sequencing of the truncation breakpoint, stable inheritance confirmed by family studies","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — direct molecular characterization of chromosome truncation with sequence validation; cited >258 times","pmids":["1975428"],"is_preprint":false},{"year":2022,"finding":"Overexpression of HBA1 in K562 AML cells inhibited proliferation, induced apoptosis, and arrested the cell cycle at G2/M phase, whereas endogenous HBA1 expression was significantly reduced in AML patient samples and cell lines, implicating HBA1 as a potential tumour suppressor in acute myeloid leukaemia.","method":"RT-qPCR in patient samples, transfection/overexpression in K562 cells, CCK-8 proliferation assay, flow cytometry (apoptosis and cell cycle)","journal":"Hematology (Amsterdam, Netherlands)","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-expression and gain-of-function with multiple cellular readouts; single lab, no rescue or pathway mechanistic follow-up","pmids":["36117408"],"is_preprint":false},{"year":2017,"finding":"The HBA1 variant Hb Amsterdam-A1 [α32(B13)Met→Ile; HBA1:c.99G>A] is hyperunstable due to perturbation of globin–heme and potentially α1β1 subunit interactions; the variant was detectable in erythrocyte precipitates (55% of alpha chains) but only 2.5% in the lysate, confirmed by isopropanol stability test and mass spectrometry, demonstrating rapid co-translational or early post-translational degradation.","method":"Isopropanol stability test, mass spectrometry of precipitate and lysate fractions","journal":"Hemoglobin","confidence":"Medium","confidence_rationale":"Tier 2 — two orthogonal biochemical methods establishing the mechanism of instability; single lab","pmids":["28696843"],"is_preprint":false},{"year":2017,"finding":"The HBA1 insertion variant Hb Bakersfield [HBA1:c.151_152insGGAGCC, inserting Arg-Ser between α49 and α51] produces a stable haemoglobin with increased oxygen affinity, as demonstrated by oxygen affinity testing and isopropanol stability assay in the heterozygous carrier.","method":"HPLC quantification, isopropanol stability test, oxygen affinity testing","journal":"Hemoglobin","confidence":"Low","confidence_rationale":"Tier 3 — functional oxygen affinity measurement but single case, single lab","pmids":["28532286"],"is_preprint":false},{"year":2015,"finding":"A novel HBA1 variant Hb G-Waimanalo [A1] [α64(E13)Asp→Asn; HBA1:c.193G>A] was found to have decreased oxygen affinity compared to normal haemoglobin, as shown by direct oxygen dissociation curve analysis.","method":"Cation exchange HPLC, DNA sequencing, oxygen affinity measurement (oxygen dissociation curve)","journal":"Hemoglobin","confidence":"Low","confidence_rationale":"Tier 3 — direct oxygen affinity measurement; single case report","pmids":["26291968"],"is_preprint":false},{"year":2019,"finding":"Homozygosity for Hb Charlieu [α106(G13)Leu→Pro; HBA1:c.320T>C] causes a hyperunstable alpha-globin protein: qPCR confirmed normal αCharlieu mRNA levels, but the protein was undetectable by standard electrophoretic methods in erythrocytes and only detectable by mass spectrometry in erythroid progenitors, indicating the mutation causes post-translational protein instability (likely during RBC maturation). New methylene blue-stained aggregates in reticulocytes suggested that incorporation of αCharlieu destabilizes haemoglobin tetramers.","method":"qPCR (mRNA stability), capillary electrophoresis, reverse-phase electrophoresis, isoelectric focusing, mass spectrometry of erythroid progenitors, heat stability test, reticulocyte inclusion body staining","journal":"Hemoglobin","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods distinguishing mRNA from protein instability, mechanistic insight into degradation during erythroid maturation; single lab","pmids":["31190578"],"is_preprint":false},{"year":2025,"finding":"Two novel HBA1 mutations in the 3'UTR (c.*119_120insT and c.*150C>A) cause alpha-thalassaemia; in silico structural modelling predicted disruption of RNA secondary structure, impaired binding of RNA-stabilising proteins HuR and AUF1, altered microRNA (miR-16-5p) binding sites, and interference with polyadenylation signals, collectively resulting in mRNA instability and reduced alpha-globin synthesis.","method":"Direct Sanger sequencing, in silico RNA secondary structure prediction, in silico protein–RNA interaction modelling (HuR, AUF1), in silico miRNA binding prediction","journal":"Annals of hematology","confidence":"Low","confidence_rationale":"Tier 4 — purely computational/in silico mechanistic inference; no experimental mRNA stability or binding validation","pmids":["41388082"],"is_preprint":false},{"year":2025,"finding":"A novel HBA1 missense mutation (NM_000558.5:c.85G>C, p.Ala29Pro) designated Hb Tozeur was predicted by in silico structural modelling (Swiss-PdbViewer, DynaMut) to destabilize the alpha-globin protein, reduce thermodynamic stability, and alter flexibility near the heme-binding region, consistent with its clinical presentation as alpha-thalassaemia.","method":"In silico pathogenicity prediction (PolyPhen-2, SIFT, MutationTaster), structural homology modelling, DynaMut stability prediction","journal":"Annals of hematology","confidence":"Low","confidence_rationale":"Tier 4 — in silico structural prediction only; no wet-lab validation of protein stability or heme binding","pmids":["40484869"],"is_preprint":false}],"current_model":"HBA1-encoded haemoglobin alpha is mechanistically established as an oxygen-binding subunit of the haemoglobin tetramer whose R/T allosteric transitions are structurally defined at atomic resolution; it undergoes nonenzymatic glycosylation at specific lysine residues; its 3'-mRNA polyadenylation depends on the conserved AAUAAA signal; in arterial endothelial cells it localises to the myoendothelial junction where its Fe(3+)/Fe(2+) redox state, controlled by CYB5R3, gates eNOS-derived NO signalling to vascular smooth muscle; and recombinant di-alpha fusions prevent αβ-dimer dissociation, demonstrating the structural basis for renal clearance of free haemoglobin."},"narrative":{"teleology":[{"year":1975,"claim":"The first atomic model of the T-state (deoxy) hemoglobin quaternary structure established how the alpha and beta subunits are arranged in the low-affinity conformation, providing the structural foundation for understanding cooperative oxygen binding.","evidence":"X-ray crystallography of human deoxyhemoglobin at 2.5 Å resolution","pmids":["1177322"],"confidence":"High","gaps":["R-state (oxy) structure not yet determined at comparable resolution","No structural basis for the T→R transition mechanism"]},{"year":1976,"claim":"Identification of the AAUAAA hexanucleotide as the conserved polyadenylation signal in alpha- and beta-globin mRNAs established how the 3' end of HBA1 mRNA is processed, a mechanism later shown to be universal for eukaryotic mRNAs.","evidence":"Direct RNA sequencing of purified human and rabbit globin mRNAs","pmids":["822353"],"confidence":"High","gaps":["Protein factors recognizing AAUAAA not yet identified","Functional consequence of signal disruption on alpha-globin expression not tested"]},{"year":1980,"claim":"Mapping nonenzymatic glycosylation to specific lysine residues (preferentially Lys16α) on the alpha chain defined the molecular basis for glycated hemoglobin species (HbA1c), explaining how post-translational modification occurs on HBA1-encoded protein.","evidence":"In vitro glycosylation with [¹⁴C]-glucose, peptide mapping, and sequencing","pmids":["7358733"],"confidence":"High","gaps":["Effect of glycosylation on oxygen affinity or allosteric cooperativity not quantified","In vivo glycosylation kinetics not measured"]},{"year":1983,"claim":"The R-state (oxy) crystal structure at 2.1 Å revealed the alpha subunit iron-oxygen geometry, the distal HisE7 hydrogen bond to O₂, and the loss of T-state salt bridges at Arg141α, completing the structural picture of the allosteric mechanism.","evidence":"Single-crystal X-ray analysis of human oxyhemoglobin","pmids":["6644819"],"confidence":"High","gaps":["Whether additional quaternary intermediates exist between T and R states was unknown","Dynamic pathway of the T→R transition unresolved"]},{"year":1990,"claim":"A chromosome 16p13.3 terminal truncation that deleted the alpha-globin regulatory region demonstrated that the chromosomal context upstream of HBA1 is essential for expression, and linked disruption of this locus to alpha-thalassemia.","evidence":"Southern blotting, PFGE, DNA sequencing of breakpoint, and family studies","pmids":["1975428"],"confidence":"High","gaps":["Specific cis-regulatory elements required for HBA1 expression not delineated","Mechanism by which telomeric healing stabilized the truncation not fully explored"]},{"year":1992,"claim":"Discovery of the R2 quaternary state and engineering of di-alpha hemoglobin answered two long-standing questions: whether additional stable allosteric conformations exist (yes—the R2 state differs at the α1β2 interface), and whether preventing αβ-dimer dissociation could eliminate renal toxicity of cell-free hemoglobin (yes—tandem alpha-globin fusion extended in vivo half-life).","evidence":"X-ray crystallography at 1.7 Å (R2 state); recombinant di-alpha Hb expression in E. coli with oxygen affinity and pharmacokinetic validation","pmids":["1512262","1552945"],"confidence":"High","gaps":["Physiological relevance of R2 state in vivo not demonstrated","Whether additional quaternary intermediates exist beyond R, R2, and T"]},{"year":2006,"claim":"Ultra-high-resolution structures (1.25 Å) of oxy-, deoxy-, and CO-hemoglobin resolved subtle differences in distal HisE7 hydrogen-bond geometry between alpha and beta subunits, explaining why HisE7 mutations produce different phenotypes in each chain.","evidence":"X-ray crystallography at 1.25 Å for three ligation states","pmids":["16765986"],"confidence":"High","gaps":["Dynamic motions of HisE7 during ligand entry and exit not captured by crystallography","Contribution of each subunit to overall cooperativity still debated"]},{"year":2012,"claim":"Discovery that hemoglobin α is expressed in arterial endothelial cells and enriched at the myoendothelial junction—where its redox state controlled by CYB5R3 gates NO diffusion to smooth muscle—established a non-canonical vascular signaling role entirely distinct from erythrocyte oxygen transport.","evidence":"Co-immunoprecipitation, subcellular fractionation, immunofluorescence, siRNA/knockout mice, pharmacological inhibition, ex vivo vascular reactivity","pmids":["23123858"],"confidence":"High","gaps":["Mechanism of Hbα targeting to the myoendothelial junction unknown","Whether endothelial Hbα expression is regulated independently of erythroid Hbα","Structural basis for the Hbα–eNOS interaction not defined"]},{"year":2017,"claim":"Characterization of hyperunstable HBA1 variants (Hb Amsterdam-A1 and others) showed that specific missense mutations cause rapid post-translational degradation of alpha-globin protein despite normal mRNA levels, demonstrating that heme pocket and subunit-interface integrity are critical for alpha-globin proteostatic stability during erythroid maturation.","evidence":"Isopropanol stability testing, mass spectrometry of precipitate and lysate fractions, qPCR of mRNA in erythroid progenitors","pmids":["28696843","31190578"],"confidence":"Medium","gaps":["Proteolytic pathway responsible for degradation of hyperunstable alpha-globin not identified","Whether AHSP stabilizes these variants in vivo not tested"]},{"year":2022,"claim":"Overexpression of HBA1 in AML cells inhibited proliferation and induced apoptosis, raising the possibility of a tumor-suppressive role outside erythroid lineages, though the downstream pathway remains uncharacterized.","evidence":"RT-qPCR in patient samples, transfection/overexpression in K562 cells, CCK-8 assay, flow cytometry","pmids":["36117408"],"confidence":"Medium","gaps":["Mechanism linking HBA1 expression to apoptosis and G2/M arrest not defined","Not independently replicated in non-K562 AML models","Whether this reflects an oxygen/NO-dependent or novel function is unknown"]},{"year":null,"claim":"Key unresolved questions include the molecular basis for Hbα targeting to the myoendothelial junction, whether endothelial and erythroid Hbα transcription is controlled by distinct regulatory programs, and the identity of the proteolytic machinery that degrades hyperunstable alpha-globin variants during erythropoiesis.","evidence":"","pmids":[],"confidence":"High","gaps":["Mechanism of Hbα localization to myoendothelial junctions unknown","Proteolytic pathway for hyperunstable alpha-globin variants unidentified","Non-canonical (non-erythroid) functions of Hbα lack systematic characterization"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[1,2,4,6]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,5]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,2,6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7]}],"complexes":["Hemoglobin tetramer (α₂β₂)"],"partners":["HBB","CYB5R3","NOS3"],"other_free_text":[]},"mechanistic_narrative":"HBA1 encodes the alpha subunit of the adult hemoglobin tetramer (HbA, α₂β₂), an oxygen-transport hemoprotein whose cooperative ligand binding is governed by allosteric R↔T quaternary transitions defined by atomic-resolution crystal structures of the deoxy (T), oxy (R), and a third stable R2 quaternary state [PMID:1177322, PMID:6644819, PMID:1512262, PMID:16765986]. In the alpha subunit, the distal histidine (HisE7) hydrogen-bonds the O₂ ligand, the iron atom sits near the porphyrin plane in the R-state, and C-terminal Arg141α participates in intersubunit salt bridges that stabilize the T-state; nonenzymatic glycosylation occurs preferentially at Lys16α and other surface lysines, generating HbA1c species [PMID:6644819, PMID:7358733]. Beyond erythrocytes, hemoglobin α is expressed in arterial endothelial cells and enriched at the myoendothelial junction, where its Fe³⁺/Fe²⁺ redox state—regulated by CYB5R3—gates eNOS-derived nitric oxide diffusion to vascular smooth muscle, establishing a non-canonical role in vascular tone regulation [PMID:23123858]. Loss-of-function mutations in HBA1 cause alpha-thalassemia, as demonstrated by chromosomal truncations removing the locus and by hyperunstable variants that undergo post-translational degradation during erythroid maturation [PMID:1975428, PMID:31190578]."},"prefetch_data":{"uniprot":{"accession":"P69905","full_name":"Hemoglobin subunit alpha","aliases":["Alpha-globin","Hemoglobin alpha chain"],"length_aa":142,"mass_kda":15.3,"function":"Involved in oxygen transport from the lung to the various peripheral tissues Hemopressin acts as an antagonist peptide of the cannabinoid receptor CNR1 (PubMed:18077343). Hemopressin-binding efficiently blocks cannabinoid receptor CNR1 and subsequent signaling (PubMed:18077343)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P69905/entry"},"depmap":{"release":"DepMap","has_data":false,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HBA1"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HBA1","total_profiled":1310},"omim":[{"mim_id":"617981","title":"ERYTHROCYTOSIS, FAMILIAL, 7; ECYT7","url":"https://www.omim.org/entry/617981"},{"mim_id":"617973","title":"METHEMOGLOBINEMIA, ALPHA TYPE","url":"https://www.omim.org/entry/617973"},{"mim_id":"617649","title":"UBIQUITIN-CONJUGATING ENZYME E2 O; UBE2O","url":"https://www.omim.org/entry/617649"},{"mim_id":"614206","title":"CHROMATIN TARGET OF PRMT1; CHTOP","url":"https://www.omim.org/entry/614206"},{"mim_id":"613978","title":"HEMOGLOBIN H DISEASE; HBH","url":"https://www.omim.org/entry/613978"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":22913.0}],"url":"https://www.proteinatlas.org/search/HBA1"},"hgnc":{"alias_symbol":["HBA-T3"],"prev_symbol":[]},"alphafold":{"accession":"P69905","domains":[{"cath_id":"1.10.490.10","chopping":"4-137","consensus_level":"high","plddt":98.3884,"start":4,"end":137}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P69905","model_url":"https://alphafold.ebi.ac.uk/files/AF-P69905-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P69905-F1-predicted_aligned_error_v6.png","plddt_mean":98.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HBA1","jax_strain_url":"https://www.jax.org/strain/search?query=HBA1"},"sequence":{"accession":"P69905","fasta_url":"https://rest.uniprot.org/uniprotkb/P69905.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P69905/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P69905"}},"corpus_meta":[{"pmid":"20680035","id":"PMC_20680035","title":"Pitfalls in the use of HbA₁(c) as a diagnostic test: the ethnic conundrum.","date":"2010","source":"Nature reviews. Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20680035","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20886203","id":"PMC_20886203","title":"HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.","date":"2010","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/20886203","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12896976","id":"PMC_12896976","title":"Schizosaccharomyces pombe cells lacking the Ran-binding protein Hba1 show a multidrug resistance phenotype due to constitutive nuclear accumulation of Pap1.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12896976","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26824843","id":"PMC_26824843","title":"In-Silico Computing of the Most Deleterious nsSNPs in HBA1 Gene.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26824843","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20849430","id":"PMC_20849430","title":"The TCF7L2 diabetes risk variant is associated with HbA₁(C) levels: a genome-wide association meta-analysis.","date":"2010","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20849430","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3662394","id":"PMC_3662394","title":"The value of HbA1 and fructosamine in predicting impaired glucose tolerance--an alternative to OGTT to detect diabetes mellitus or gestational diabetes.","date":"1987","source":"Annals of clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3662394","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16503550","id":"PMC_16503550","title":"Determining the cause of patchwork HBA1 and HBA2 genes: recurrent gene conversion or crossing over fixation events.","date":"2006","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/16503550","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4090971","id":"PMC_4090971","title":"Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1.","date":"1985","source":"Acta paediatrica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/4090971","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20353346","id":"PMC_20353346","title":"Two new alpha1-globin gene point mutations: Hb Nedlands (HBA1:c.86C>T) [alpha28(B9)Ala-->Val] and Hb Queens Park (HBA1:c.98T>A) [alpha32(B13)Met-->Lys].","date":"2010","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/20353346","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29749692","id":"PMC_29749692","title":"Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype-phenotype correlation.","date":"2018","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29749692","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24081251","id":"PMC_24081251","title":"Clinical presentation and molecular identification of four uncommon alpha globin variants in Thailand. Initiation codon mutation of α2-globin Gene (HBA2:c.1delA), donor splice site mutation of α1-globin gene (IVSI-1, HBA1:c.95 + 1G>A), hemoglobin Queens Park/Chao Pra Ya (HBA1:c.98T>A) and hemoglobin Westmead (HBA2:c.369C>G).","date":"2013","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/24081251","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36117408","id":"PMC_36117408","title":"Decreased expression of HBA1 and HBB genes in acute myeloid leukemia patients and their inhibitory effects on growth of K562 cells.","date":"2022","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/36117408","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24829075","id":"PMC_24829075","title":"A case series of α-thalassemia intermedia due to compound heterozygosity for Hb Adana [HBA2: c179G>A (or HBA1); p.Gly60Asp] with other α-thalassemias in Malay families.","date":"2014","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24829075","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24826791","id":"PMC_24826791","title":"Screening and diagnosis of Hb Quong Sze [HBA2: c.377T > C (or HBA1)] in a prenatal control program for thalassemia.","date":"2014","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24826791","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36453528","id":"PMC_36453528","title":"Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36453528","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4026185","id":"PMC_4026185","title":"Comparison of three different assay procedures for the determination of HbA1 with special attention to the influence of pre-HbA1c, temperature and haemoglobin concentration.","date":"1985","source":"Annals of clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/4026185","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35052472","id":"PMC_35052472","title":"Importance of Sequencing HBA1, HBA2 and HBB Genes to Confirm the Diagnosis of High Oxygen Affinity Hemoglobin.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35052472","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32597240","id":"PMC_32597240","title":"Identification of a new hemoglobin variant Hb Liuzhou [HBA1:C.182A→G] by MALDI-TOF mass spectrometry during HbA1c measurement.","date":"2020","source":"Scandinavian journal of clinical and laboratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32597240","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6530003","id":"PMC_6530003","title":"Haemoglobinopathies, malaria, and other interferences with HBA1 assessment.","date":"1984","source":"Diabete & metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/6530003","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25342395","id":"PMC_25342395","title":"Homozygosity for HBA1: c.179G > A: Hb Adana in an infant.","date":"2014","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/25342395","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24716903","id":"PMC_24716903","title":"A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death.","date":"2014","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/24716903","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28696843","id":"PMC_28696843","title":"Hb Amsterdam-A1 [α32(B13)Met→Ile; HBA1: c.99G>A]: A Hyperunstable Variant Due to a New Mutation on the α1 Gene.","date":"2017","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/28696843","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28532286","id":"PMC_28532286","title":"Hb Bakersfield (HBA1: c.151_152insGGAGCC): The Insertion of Arg-His Between Codons 49 and 50 of the α1-Globin Chain Leads to Increased Oxygen Affinity.","date":"2017","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/28532286","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29620819","id":"PMC_29620819","title":"FIRST IDENTIFICATION OF HEMOGLOBIN LANSINGRAMATHIBODI [α87(F8)His → Gln; CAC>CAG (HBA1: c.264C>G)] IN A THAI FAMILY WITH SPURIOUS HYPOXEMIA.","date":"2016","source":"The Southeast Asian journal of tropical medicine and public health","url":"https://pubmed.ncbi.nlm.nih.gov/29620819","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32924661","id":"PMC_32924661","title":"Fifteen Cases of Hb J-Meerut: The Rare Association with Hb E and/or HBA1: c.-24C>G (or HBA2) Variants.","date":"2020","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/32924661","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29405838","id":"PMC_29405838","title":"Hb Nouakchott [α114(GH2)Pro→Leu; HBA1: c.344C>T], A Second and Third Case Described in Two Unrelated Dutch Families.","date":"2018","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/29405838","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26683685","id":"PMC_26683685","title":"Development and validation of a high throughput, closed tube method for the determination of haemoglobin alpha gene (HBA1 and HBA2) numbers by gene ratio assay copy enumeration-PCR (GRACE-PCR).","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26683685","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22738642","id":"PMC_22738642","title":"Identification of a new HBA1 gene mutation (HBA1:c.301-2A>T) in cis with Hb Riccarton (HBA1:c.154G>A) [α51(CE9)Gly→Ser].","date":"2012","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/22738642","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30375897","id":"PMC_30375897","title":"Falsely high HbA1c value due to a novel α1-globin gene mutation: Hb shantou [α127(H10)Lys > Glu; HBA1: c.382 A > G].","date":"2018","source":"Scandinavian journal of clinical and laboratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30375897","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24826793","id":"PMC_24826793","title":"Novel point mutation of the α2-globin gene (HBA2) and a rare 2.4 kb deletion of the α1-globin gene (HBA1), identified in two chinese patients with Hb H disease.","date":"2014","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24826793","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38581097","id":"PMC_38581097","title":"A clinical update of compound heterozygosity for hemoglobin Hekinan II [a27(B8)Glu-Asp; HBA1: c.84G>T] variant in China.","date":"2024","source":"Laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38581097","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32811243","id":"PMC_32811243","title":"Pedigree Analysis of Nonhomologous Sequence Recombination of HBA1 and HBA2 Genes.","date":"2020","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/32811243","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35611053","id":"PMC_35611053","title":"Effects of Senegal haplotype (Xmn1-rs7412844), alpha-thalassemia (3.7kb HBA1/HBA2 deletion), NPRL3-rs11248850 and BCL11A-rs4671393 variants on sickle cell nephropathy.","date":"2022","source":"International journal of biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35611053","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30277418","id":"PMC_30277418","title":"Hb Hubei [α114(GH2)Pro→His, HBA1: c.344C>A]: A Novel Hemoglobin Variant of the α1-Globin Chain.","date":"2018","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/30277418","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24432778","id":"PMC_24432778","title":"Hb Memphis [HBA2: c.70G>C (or HBA1)] in a Turkish child: a case report and comparison to Hb Q-Thailand (HBA1: c.223G>C).","date":"2014","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24432778","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24136020","id":"PMC_24136020","title":"Variable genotype-phenotype correlations in patients with a rare nondeletional α-thalassemia; Hb Pak Num Po (HBA1: c.396_397insT).","date":"2014","source":"Journal of pediatric hematology/oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24136020","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26100115","id":"PMC_26100115","title":"Description of Three New α Variants and Four New β Variants: Hb Montluel [α110(G17)Ala → Val; HBA1: c.332C > T], Hb Cap d'Agde [α131(H14)Ser → Cys; HBA2: c.395C > G] and Hb Corsica [α100(G7)Leu → Pro; HBA1: 302T > C]; Hb Nîmes [β104(G6)Arg → Gly; HBB: c.313A > G], Hb Saint Marcellin [β112(G14)Cys → Gly; HBB: c.337T > G], Hb Saint Chamond [β80(EF4)Asn → 0; HBB: c.241_243delAAC] and Hb Dompierre [β29(B11)Gly → Arg; HBB: c.88G > C].","date":"2015","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/26100115","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25892676","id":"PMC_25892676","title":"Multi-allele DNA biosensor for the rapid genotyping of 'nondeletion' alpha thalassaemia mutations in HBA1 and HBA2 genes by means of multiplex primer extension reaction.","date":"2015","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25892676","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26035111","id":"PMC_26035111","title":"Screening non-deletion α-thalassaemia mutations in the HBA1 and HBA2 genes by high-resolution melting analysis.","date":"2015","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26035111","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26531168","id":"PMC_26531168","title":"Identification of Mutations Causing Aberrant Termination and Deficient Splice Donor Site on the HBA1 Gene.","date":"2015","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/26531168","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25669128","id":"PMC_25669128","title":"A novel hemoglobin variant found on the α1 chain: Hb KSVGH (HBA1: p.Lys57_Gly58insSerHisGlySerAlaGlnValLys).","date":"2015","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/25669128","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6670118","id":"PMC_6670118","title":"Glycosylated haemoglobin (HbA1) for diabetic control in Africans; preliminary findings with the microcolumn technique.","date":"1983","source":"Tropical and geographical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/6670118","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29484903","id":"PMC_29484903","title":"Complex Interaction of Hb Q-Thailand (HBA1: c.223G>C) with β-Thalassemia/Hb E (HBB: c.79G>A) Disease.","date":"2018","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/29484903","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34082638","id":"PMC_34082638","title":"A Novel Mutation at HBA1: c.349G>T Causing α-Thalassemia in a Chinese Family.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/34082638","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6404988","id":"PMC_6404988","title":"Genetic control of the immune response to human adult haemoglobin (HbA1) and sickle cell haemoglobin (HbS).","date":"1983","source":"Journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/6404988","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40484869","id":"PMC_40484869","title":"Revealing silent alpha-thalassemia: characterization of novel HBA1 deletion and missense mutation in Tunisian families.","date":"2025","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/40484869","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32727229","id":"PMC_32727229","title":"α-Thalassemia Intermedia Results from Interactions of Unstable Hb Prato [α31(B12)Arg→Ser (HBA1 or HBA2 c.96G>T or C)] with the α-Thalassemia-1 [- -SEA (Southeast Asian)] Deletion in Thailand.","date":"2020","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/32727229","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36000508","id":"PMC_36000508","title":"A New Hemoglobin Variant, Hb Natal (HBA1: c.423C>A), Found in a Greek Family.","date":"2022","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/36000508","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34784833","id":"PMC_34784833","title":"Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable α Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/34784833","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31650882","id":"PMC_31650882","title":"Compound Heterozygosity for an Unstable Novel Hemoglobin Variant, Hb Dongguan [α52(E1)Ser→Cys (TCT>TGT); HBA1: c.158C>G], and the - -SEA (Southeast Asian) α-Thalassemia Deletion.","date":"2019","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/31650882","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24006930","id":"PMC_24006930","title":"Hb Fulton-Georgia [α20(B1)His→Pro; HBA1: c.62A>C]: a new α-globin variant coinherited with α-thalassemia-2 (3.7 kb deletion) and Hb SC disease.","date":"2013","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24006930","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28641501","id":"PMC_28641501","title":"Hematological Characterizations and Molecular Diagnostic Aspects of Hb Wiangpapao [α44(CE2)Pro→Ser (α1), CCG>TCG; HBA1: c.133C>T], a New α-Globin Variant Found in a Pregnant Thai Woman.","date":"2017","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/28641501","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39312720","id":"PMC_39312720","title":"Interactions of electrophoretically silent hemoglobin Hekinan II [HBA1:c.84G>T] with various forms of α-thalassemias and other hemoglobinopathies: novel insights into the molecular and hematological characteristics and genetic origins.","date":"2024","source":"The Libyan journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39312720","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23806041","id":"PMC_23806041","title":"Coinheritance of a novel mutation on the HBA1 gene: c.187delG (p.W62fsX66) [codon 62 (-G) (α1)] with the α212 patchwork allele and Hb S [β6(A3)Glu→Val, GAG>GTG; HBB: c.20A>T].","date":"2013","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/23806041","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23470151","id":"PMC_23470151","title":"Codon 62 (GTG>GCG, Val→Ala) (α1) (HBA1: c.188T>C) causing nondeletional α-thalassemia in a Chinese family.","date":"2013","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/23470151","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34496687","id":"PMC_34496687","title":"Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/34496687","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33023349","id":"PMC_33023349","title":"Association of Hb Shenyang [α26(B7)Ala→Glu, GCG>GAG, HBA2: c.80C>A (or HBA1)] with Several Types of α-Thalassemia in Thailand.","date":"2020","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/33023349","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26852627","id":"PMC_26852627","title":"Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [HBA2: c.269A>T (or HBA1)] and α-Thalassemia: A Clinical Update.","date":"2016","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/26852627","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33675809","id":"PMC_33675809","title":"Hb Maruchi [α165 (E14) Ala>Pro; HBA1: c.196G>C]: A new thalassemia hemoglobinopathy related to the alpha1 globin gene.","date":"2021","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33675809","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39878036","id":"PMC_39878036","title":"Comprehensive Hematological and molecular Characterization of hemoglobin Hekinan [α27(B8)Glu→Asp(α1), HBA1:c.84G > T] in a Large Thai cohort.","date":"2025","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/39878036","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31190578","id":"PMC_31190578","title":"A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic Anemia.","date":"2019","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/31190578","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24111644","id":"PMC_24111644","title":"Description of the phenotypes of 63 heterozygous, homozygous and compound heterozygous patients carrying the Hb Groene Hart [α119(H2)Pro→Ser; HBA1: c.358C>T] variant.","date":"2013","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/24111644","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36847654","id":"PMC_36847654","title":"Hb Nivaria: A New Hemoglobin Variant with a Shortened α-Globin Chain [α139(HC1)Lys→Stop; HBA1: c.418A>T].","date":"2023","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/36847654","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27821014","id":"PMC_27821014","title":"Novel Mutation of the Translation Initiation Codon of the α1-Globin Gene (ATG>AAG or HBA1:c.2T>A).","date":"2016","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/27821014","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26212674","id":"PMC_26212674","title":"Hb G-Waimanalo [A1] or α64(E13)Asp→Asn (α1) (HBA1: c.193G>A) Observed in a Bulgarian Family.","date":"2015","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/26212674","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26291968","id":"PMC_26291968","title":"Hb G-Waimanalo [A1] [α64(E13)Asp→Asn; HBA1: c.193 G > A] with Decreased Oxygen Affinity.","date":"2015","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/26291968","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2188196","id":"PMC_2188196","title":"[The significance of HbA1 determination in children].","date":"1990","source":"Padiatrie und Grenzgebiete","url":"https://pubmed.ncbi.nlm.nih.gov/2188196","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30595158","id":"PMC_30595158","title":"Novel nonsense mutation in the α1-globin gene [HBA1:C.49A>T] is responsible for non-deletion α-thalassemia.","date":"2018","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30595158","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11808628","id":"PMC_11808628","title":"Chromosomal mapping of calmodulin 1 (CALM1) and alpha-globin 1 genes (HBA1) in the bovine.","date":"2001","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/11808628","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32783538","id":"PMC_32783538","title":"Hb broomhill [α1 or α2 114(GH2) pro > ala;HBA1 or HBA2:c.343C > G]: a rare Hb variant found in a diabetic chinese individual.","date":"2020","source":"Scandinavian journal of clinical and laboratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32783538","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33792470","id":"PMC_33792470","title":"Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/33792470","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30728682","id":"PMC_30728682","title":"First Report of Association Between Rare α-Thalassemia Mutation (HBA1: c.298A>T) and Hb Fontainebleau (HBA2: c.64G>C).","date":"2018","source":"Indian journal of clinical biochemistry : IJCB","url":"https://pubmed.ncbi.nlm.nih.gov/30728682","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33478272","id":"PMC_33478272","title":"Hb Waikato [α127(H10)Lys→Gln; HBA1: c.382A>C]: A Novel High Oxygen Affinity Variant.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/33478272","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38965958","id":"PMC_38965958","title":"Hb Guigang [α90 (FG2)Lys→Asn; HBA1:c.273G˃T]: a Novel α-Globin Chain Variant.","date":"2024","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/38965958","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37909121","id":"PMC_37909121","title":"A New Hemoglobin Variant: Hb Tangshan [HBA1: c.239C > T, CD79(GCG > GTG)(Ala > Val)] Detected by MALDI-TOF MS.","date":"2023","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/37909121","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33792465","id":"PMC_33792465","title":"Identification of Two Novel Thalassemia Variants, HBA1: c.263delA and HBA2: c.376dupC, in Chinese Individuals.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/33792465","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40497600","id":"PMC_40497600","title":"Rare Hemoglobin Variant Hb Handsworth (HBA1:c.55 G>C): Leads to False Positive Diagnosis of Hb S.","date":"2025","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/40497600","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41388082","id":"PMC_41388082","title":"Importance of the 3'UTR region in globin synthesis: identification of two novel HBA1 mutations causing α-Thalassemia.","date":"2025","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/41388082","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31084368","id":"PMC_31084368","title":"Hb Milano [α109(G16)Leu→Pro (CTG>CCG); HBA1: c.329T>C]: A Novel Variant on the α1-Globin Gene in an Italian Family.","date":"2019","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/31084368","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37145073","id":"PMC_37145073","title":"Hb Qinzhou [α1 78 (EF7) Asn→Lys (AAC>AAA); HBA1:c.237C>A]: a Novel α-Globin Variant in a Chinese Family.","date":"2023","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/37145073","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36815319","id":"PMC_36815319","title":"Severe Hb H Disease Caused by Hb Zürich-Albisrieden (HBA1: c.178G>C): Another Case Report.","date":"2023","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/36815319","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34802367","id":"PMC_34802367","title":"Hb Jishui [HBA1: c.225C>G, Codon 74 (GAC>GAG), Asp→Glu]: A Novel α Chain Hemoglobin Variant Detected During Hb A1c Measurement.","date":"2021","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/34802367","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2134209","id":"PMC_2134209","title":"Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.","date":"1990","source":"Diabetes research (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/2134209","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38632978","id":"PMC_38632978","title":"A New α1-Globin Variant, Hb Ormylia [HBA1:c.63C > G; p.His21Gln]. Report of Eleven Cases in Northern Greece.","date":"2024","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/38632978","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40685501","id":"PMC_40685501","title":"Novel Double Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBB: c.-78A > G and Novel Compound Heterozygosity: HBA2: c.70G > A (Hb Chad)/HBA1: c.84G > T (Hb Hekinan II) Hemoglobinopathy in a Chinese Family.","date":"2025","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/40685501","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40887457","id":"PMC_40887457","title":"Molecular Diagnosis and Stability Testing of Hemoglobin Phnom Penh [HBA1: C.353_355dup (p.Phe118_Thr119insIle)] - The First Northern Thai Case.","date":"2025","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/40887457","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41498364","id":"PMC_41498364","title":"A Novel Alpha1-Variant (HBA1:c.-35T>C) Complexed With the First Reported Hb M-Saskatoon in the Chinese Population.","date":"2026","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41498364","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41236345","id":"PMC_41236345","title":"Genetic Analysis and Clinical Relevance of :c.305T > C (Leu > Pro): A Novel Variant Linked to α-Thalassemia.","date":"2025","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/41236345","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40687478","id":"PMC_40687478","title":"Alpha-Thalassemia Caused by ααIVSI-1(AGGT> AGAT) (HBA1: c.95 + 1G > A) Mutation and its Combinations with Other Forms of Thalassemia or Hemoglobinopathy in Northern Thailand.","date":"2024","source":"Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/40687478","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38626925","id":"PMC_38626925","title":"Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two α-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.","date":"2024","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/38626925","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.08.25339626","title":"Plasma vs. serum: which is better for proteomic blood biomarker analysis? Evaluation of the novel NULISA platform","date":"2025-11-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.08.25339626","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.15.643427","title":"Structural variants contribute to the gut microbiome, blood metabolic traits, and their causal relationships","date":"2025-03-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.15.643427","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.09.658195","title":"Placental Iron Utilisation in Fetal Growth Restriction: Alterations in Mitochondrial Heme Synthesis and Iron-Sulfur Cluster Assembly Pathways","date":"2025-06-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.09.658195","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.10.21.619361","title":"Integrative Transcriptomic Profiling of NK Cells and Monocytes: Advancing Diagnostic and Therapeutic Strategies for COVID-19","date":"2024-10-21","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.21.619361","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"822353","id":"PMC_822353","title":"3' non-coding region sequences in eukaryotic messenger RNA.","date":"1976","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/822353","citation_count":2913,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"5967288","id":"PMC_5967288","title":"Abnormal human haemoglobins. Separation and characterization of the alpha and beta chains by chromatography, and the determination of two new variants, hb Chesapeak and hb J (Bangkok).","date":"1966","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/5967288","citation_count":1562,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6644819","id":"PMC_6644819","title":"Structure of human oxyhaemoglobin at 2.1 A resolution.","date":"1983","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/6644819","citation_count":505,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12665801","id":"PMC_12665801","title":"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12665801","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2649166","id":"PMC_2649166","title":"A review of the molecular genetics of the human alpha-globin gene cluster.","date":"1989","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2649166","citation_count":479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20139978","id":"PMC_20139978","title":"Genome-wide association study of hematological and biochemical traits in a Japanese population.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20139978","citation_count":406,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1177322","id":"PMC_1177322","title":"Three-dimensional fourier synthesis of human deoxyhaemoglobin at 2-5 A resolution: refinement of the atomic model.","date":"1975","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1177322","citation_count":387,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18694998","id":"PMC_18694998","title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18694998","citation_count":363,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28898252","id":"PMC_28898252","title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.","date":"2017","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28898252","citation_count":320,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"13872627","id":"PMC_13872627","title":"[The structure of normal adult human hemoglobins].","date":"1961","source":"Hoppe-Seyler's Zeitschrift fur physiologische Chemie","url":"https://pubmed.ncbi.nlm.nih.gov/13872627","citation_count":316,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7358733","id":"PMC_7358733","title":"Sites of nonenzymatic glycosylation of human hemoglobin A.","date":"1980","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7358733","citation_count":303,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6297773","id":"PMC_6297773","title":"The structure of the human zeta-globin gene and a closely linked, nearly identical pseudogene.","date":"1982","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6297773","citation_count":290,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23123858","id":"PMC_23123858","title":"Endothelial cell expression of haemoglobin α regulates nitric oxide signalling.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23123858","citation_count":272,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12200073","id":"PMC_12200073","title":"High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.","date":"2002","source":"Journal of diabetes and its complications","url":"https://pubmed.ncbi.nlm.nih.gov/12200073","citation_count":259,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1975428","id":"PMC_1975428","title":"A truncated human chromosome 16 associated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1975428","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35031058","id":"PMC_35031058","title":"EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.","date":"2022","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35031058","citation_count":257,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1552945","id":"PMC_1552945","title":"A human recombinant haemoglobin designed for use as a blood substitute.","date":"1992","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1552945","citation_count":249,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1512262","id":"PMC_1512262","title":"A third quaternary structure of human hemoglobin A at 1.7-A resolution.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1512262","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15174051","id":"PMC_15174051","title":"An investigation into the human serum \"interactome\".","date":"2004","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/15174051","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16765986","id":"PMC_16765986","title":"1.25 A resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy forms.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16765986","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42453,"output_tokens":2294,"usd":0.080884},"stage2":{"model":"claude-opus-4-6","input_tokens":5690,"output_tokens":1810,"usd":0.11055},"total_usd":0.474869,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":54177,"output_tokens":4724,"usd":0.116695},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7837,"output_tokens":2879,"usd":0.16674}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"The Hb Amsterdam-A1 variant [α32(B13)Met→Ile; HBA1: c.99G>A] on the α1 gene produces a hyperunstable α-globin chain whose instability is driven by perturbation of globin-heme and possibly α1β1 subunit interactions, as demonstrated by isopropanol stability testing and mass spectrometry showing the variant constitutes 55% of precipitate but only 2.5% of lysate.\",\n      \"method\": \"Isopropanol stability test, mass spectrometry of precipitate and lysate fractions\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal methods (stability assay + MS) in single lab identifying mechanism of instability\",\n      \"pmids\": [\"28696843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Hb Bakersfield, an insertion variant on HBA1 [c.151_152insGGAGCC] producing an extra Arg-Ser between residues 49 and 50 of the α1-globin chain, results in a stable hemoglobin with increased oxygen affinity, as demonstrated by oxygen affinity testing.\",\n      \"method\": \"HPLC quantification, stability testing, oxygen affinity measurement\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay (oxygen affinity) plus stability testing in single lab\",\n      \"pmids\": [\"28532286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hb G-Waimanalo [A1] [α64(E13)Asp→Asn; HBA1: c.193G>A] on the α1-globin gene produces a hemoglobin variant with decreased oxygen affinity compared to normal hemoglobin, as demonstrated by oxygen dissociation curve analysis.\",\n      \"method\": \"Cation exchange HPLC, DNA sequencing, oxygen affinity measurement\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single functional assay with limited mechanistic detail\",\n      \"pmids\": [\"26291968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Hb Waikato [α127(H10)Lys→Gln; HBA1: c.382A>C], a novel α1-globin chain variant, produces a high oxygen affinity hemoglobin with reduced p50 (20.8 mmHg) and left-shifted oxygen dissociation curve, while maintaining normal isopropanol stability.\",\n      \"method\": \"Capillary electrophoresis, isopropanol stability test, p50 measurement, oxygen dissociation curve\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional oxygen affinity assay plus stability testing with quantitative p50 measurement\",\n      \"pmids\": [\"33478272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Hb Charlieu [α106(G13)Leu→Pro; HBA1: c.320T>C] homozygous mutation produces mRNA that is stable (qPCR confirmed αCharlieu mRNA expression) but results in a protein that is undetectable in mature erythrocytes yet detectable by mass spectrometry in erythrocyte progenitors, indicating the mutation causes post-translational protein instability and degradation during red blood cell development, with incorporation of αCharlieu destabilizing hemoglobin and causing impaired erythropoiesis.\",\n      \"method\": \"qPCR (mRNA stability), capillary electrophoresis, reverse phase electrophoresis, isoelectric focusing, mass spectrometry of progenitor cells, heat stability test\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (mRNA quantification, multiple protein separation techniques, MS) establishing post-translational instability mechanism\",\n      \"pmids\": [\"31190578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Two novel mutations in the 3'UTR of HBA1 (HBA1:c.*119_120insT and HBA1:c.*150C>A) cause alpha-thalassemia; in silico analyses indicate these variants disrupt RNA secondary structure, impair interactions with HuR and AUF1 RNA-binding proteins, alter microRNA binding (miR-16-5p), and potentially interfere with polyadenylation signals, resulting in mRNA instability and reduced alpha-globin synthesis.\",\n      \"method\": \"Multiplex PCR, direct sequencing, in silico RNA structure and protein-binding prediction\",\n      \"journal\": \"Annals of hematology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — mechanistic claims are computational only; no experimental validation of mRNA stability or protein interactions performed\",\n      \"pmids\": [\"41388082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A novel mutation HBA1:c.2T>A at the translation initiation codon (ATG>AAG) of the α1-globin gene abolishes normal translation initiation and causes α+-thalassemia trait.\",\n      \"method\": \"DNA sequencing, hematological phenotyping\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic inference from mutation position; no in vitro translation assay performed\",\n      \"pmids\": [\"27821014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A novel splice acceptor site mutation HBA1:c.301-2A>T in cis with Hb Riccarton on the HBA1 gene leads to a non-functional α-globin chain and causes α+-thalassemia, demonstrating that disruption of the IVS2 splice acceptor of HBA1 abolishes functional protein production.\",\n      \"method\": \"PCR, cloning, direct sequencing of individual alleles\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic inference from splice site mutation position; no direct splicing assay performed\",\n      \"pmids\": [\"22738642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The missense mutation HBA1:c.85G>C (p.Ala29Pro), designated Hemoglobin Tozeur, was predicted by structural modeling (Swiss-PdbViewer and DynaMut) to destabilize the α-globin protein, reduce stability, and alter flexibility near the heme-binding region, providing a structural mechanism for the associated α-thalassemia phenotype.\",\n      \"method\": \"Sanger sequencing, in silico pathogenicity tools (PolyPhen-2, SIFT, MutationTaster), protein structural modeling\",\n      \"journal\": \"Annals of hematology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — mechanistic claims based on computational structural modeling only, no experimental biochemical validation\",\n      \"pmids\": [\"40484869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The HBA1 and HBA2 genes differ in transcriptional activity; mutations on the HBA1 gene (dominant α2 gene is HBA2) produce milder α-thalassemia phenotypes compared to equivalent HBA2 mutations, as demonstrated by comparison of a 2392 bp HBA1 deletion with other mutations causing Hb H disease.\",\n      \"method\": \"MLPA, gap-PCR breakpoint mapping, hematological phenotype comparison\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — differential phenotype comparison supporting known differential expression; no direct transcription assay in this paper\",\n      \"pmids\": [\"24826793\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HBA1 encodes the alpha-1 globin chain subunit of adult hemoglobin; point mutations or deletions in HBA1 reduce functional alpha-globin chain production (α+-thalassemia), and specific amino acid substitutions can alter hemoglobin oxygen affinity or protein stability through perturbation of heme-binding and subunit interface interactions, with HBA1 mutations generally producing milder phenotypes than equivalent HBA2 mutations due to the lower transcriptional output of HBA1 relative to HBA2.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification:**\n- Papers about S. pombe Hba1 (PMID:12896976): EXCLUDE — symbol collision, fungal protein with completely different function\n- Papers about glycosylated hemoglobin/HbA1c as a diabetes biomarker (PMIDs: 20680035, 20886203, 3662394, 20849430, 4090971, 4026185, 6530003, 2188196, 6670118, 2134209): EXCLUDE — biomarker/diagnostic studies, not mechanistic\n- Papers about HBA1 gene mutations/variants in thalassemia/hemoglobinopathies (many): KEEP only if mechanistic findings present\n- Papers about structure/function of hemoglobin (curated papers): KEEP where mechanistic\n- PMID:23123858 (endothelial Hb α and NO signaling): KEEP — strong mechanistic finding\n- PMID:6644819, 1177322, 16765986 (crystal structures): KEEP\n- PMID:1512262 (R2 quaternary structure): KEEP\n- PMID:7358733 (glycosylation sites): KEEP\n- PMID:1552945 (recombinant Hb blood substitute): KEEP — mechanistic (oxygen affinity, dimer dissociation)\n- PMID:822353 (AAUAAA polyadenylation signal): KEEP — foundational mechanistic finding about globin mRNA\n- PMID:2649166 (review of alpha-globin gene cluster): KEEP\n- PMID:1975428 (telomere stabilization): KEEP — mechanistic\n- PMID:36117408 (HBA1/HBB tumor suppressor in AML): KEEP — direct functional experiment\n- PMID:28696843 (Hb Amsterdam-A1 hyperunstable variant): KEEP — mechanism of instability\n- PMID:28532286 (Hb Bakersfield increased O2 affinity): KEEP — functional testing\n- PMID:26291968 (Hb G-Waimanalo decreased O2 affinity): KEEP\n- PMID:29620819 (Hb Lansing-Ramathibodi spurious hypoxemia): KEEP — functional implication\n- PMID:31190578 (Hb Charlieu homozygous — protein stability mechanism): KEEP\n- PMID:40484869 (Hb Tozeur structural modeling): KEEP — in silico structural\n- PMID:78378 (3'UTR mutations): KEEP — mechanistic about mRNA regulation\n- Most variant description papers without mechanistic content: EXCLUDE\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1976,\n      \"finding\": \"The hexanucleotide sequence AAUAAA (encoded by the HBA1/HBA2 and HBB mRNAs, as well as other eukaryotic mRNAs) is located approximately 20 residues upstream of the 3'-terminal poly(A) sequence and is conserved across alpha- and beta-globin mRNAs of rabbit and human, establishing it as the canonical polyadenylation signal in eukaryotic mRNAs.\",\n      \"method\": \"RNA sequencing of purified mRNAs including human and rabbit alpha- and beta-globin mRNAs\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequencing of purified mRNAs; replicated across multiple globin mRNAs and species; foundational discovery cited >2900 times\",\n      \"pmids\": [\"822353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1975,\n      \"finding\": \"Three-dimensional X-ray crystallographic refinement of human deoxyhaemoglobin at 2.5 Å resolution established the atomic model of the T-state (deoxy) quaternary structure of HbA, defining the spatial arrangement of the alpha (HBA1/HBA2) and beta subunits in the low-affinity conformation.\",\n      \"method\": \"X-ray crystallography, atomic model refinement\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure; foundational structural determination cited >380 times\",\n      \"pmids\": [\"1177322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"Crystal structure of human oxyhaemoglobin at 2.1 Å resolution revealed that the iron atom in the alpha subunit (HBA1/HBA2) is 0.16 Å from the porphyrin plane, the Fe–O bond length is 1.66 Å, and a hydrogen bond from the oxygen ligand to the distal HisE7 is present in the alpha subunit; the R-state (oxy) quaternary structure was confirmed, with the C-terminal ArgHC3(141α) unable to form T-state intersubunit salt bridges.\",\n      \"method\": \"Single crystal X-ray analysis, Jack-Levitt refinement\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with detailed active-site geometry; cited >500 times\",\n      \"pmids\": [\"6644819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1980,\n      \"finding\": \"Nonenzymatic glycosylation of human haemoglobin A occurs at multiple specific lysine residues on both the alpha (HBA1) and beta chains; the alpha chain is glycosylated preferentially at LysA16(α16) and other surface lysines, establishing the molecular basis for HbA1c and related glycated haemoglobin species.\",\n      \"method\": \"In vitro glycosylation assay with [14C]-glucose followed by peptide mapping and sequencing of glycated peptides\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical identification of glycation sites by peptide mapping; cited >300 times\",\n      \"pmids\": [\"7358733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Human haemoglobin adopts a third stable quaternary structure (R2-state) for liganded HbA at 1.7 Å resolution; in the R2-state the α1β2 interface 'switch' region (His97β) rotates away from Thr38α1 and Thr41α1, opening the interface and potentially functioning as a stable intermediate on an R→R2→T pathway during allosteric transition of the alpha (HBA1) and beta subunits.\",\n      \"method\": \"X-ray crystallography at 1.7 Å resolution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure revealing a novel quaternary state; cited >247 times\",\n      \"pmids\": [\"1512262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"A recombinant human haemoglobin with tandemly fused (di-alpha) alpha-globin subunits (encoded by HBA1) and a mutant beta-globin with reduced oxygen affinity was expressed in E. coli and shown to function as a blood substitute: fusion of the two alpha subunits prevented dissociation into αβ dimers (increasing in vivo half-life and eliminating renal toxicity) and the beta mutation restored physiologically appropriate oxygen unloading.\",\n      \"method\": \"Recombinant protein expression in E. coli, in vitro oxygen affinity measurements, in vivo pharmacokinetic studies\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and functional validation; cited >249 times\",\n      \"pmids\": [\"1552945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structures of human haemoglobin in oxy, deoxy, and carbonmonoxy forms refined to 1.25 Å resolution clarified that the distal histidine (HisE7) forms a hydrogen bond to the oxygen ligand in both the alpha (HBA1) and beta subunits in the R-state, and revealed subtle geometric differences in the hydrogen-bond geometry between subunits that explain differential phenotypes when HisE7 is mutated in alpha versus beta globin.\",\n      \"method\": \"High-resolution X-ray crystallography (1.25 Å) for three liganded states\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — highest-resolution crystal structures of all three ligation states; cited >235 times\",\n      \"pmids\": [\"16765986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Haemoglobin alpha (encoded by HBA1/HBA2) is expressed in arterial endothelial cells and is enriched at the myoendothelial junction, where it regulates nitric oxide (NO) signalling: Hb α in the Fe(3+) (met) state permits eNOS-derived NO to reach vascular smooth muscle, whereas reduction to Fe(2+) by endothelial cytochrome b5 reductase 3 (CYB5R3) quenches NO bioactivity. Genetic depletion of Hb α or pharmacological inhibition of CYB5R3 altered vascular reactivity in small arteries.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation/immunofluorescence localization, genetic knockdown (siRNA/knockout mice), pharmacological inhibition, ex vivo vascular reactivity assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (localization, KO phenotype, pharmacological rescue) in a single study; cited >272 times\",\n      \"pmids\": [\"23123858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"A terminal truncation of chromosome 16p13.3 to a site 50 kb distal to the alpha-globin gene cluster (causing alpha-thalassaemia) was stabilized by direct addition of telomeric (TTAGGG)n repeats to the break site, demonstrating that telomeric DNA alone is sufficient to cap and stabilize a broken chromosome end; this also defined the chromosomal context essential for normal HBA1 expression.\",\n      \"method\": \"Southern blotting, pulsed-field gel electrophoresis, DNA sequencing of the truncation breakpoint, stable inheritance confirmed by family studies\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular characterization of chromosome truncation with sequence validation; cited >258 times\",\n      \"pmids\": [\"1975428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Overexpression of HBA1 in K562 AML cells inhibited proliferation, induced apoptosis, and arrested the cell cycle at G2/M phase, whereas endogenous HBA1 expression was significantly reduced in AML patient samples and cell lines, implicating HBA1 as a potential tumour suppressor in acute myeloid leukaemia.\",\n      \"method\": \"RT-qPCR in patient samples, transfection/overexpression in K562 cells, CCK-8 proliferation assay, flow cytometry (apoptosis and cell cycle)\",\n      \"journal\": \"Hematology (Amsterdam, Netherlands)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-expression and gain-of-function with multiple cellular readouts; single lab, no rescue or pathway mechanistic follow-up\",\n      \"pmids\": [\"36117408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The HBA1 variant Hb Amsterdam-A1 [α32(B13)Met→Ile; HBA1:c.99G>A] is hyperunstable due to perturbation of globin–heme and potentially α1β1 subunit interactions; the variant was detectable in erythrocyte precipitates (55% of alpha chains) but only 2.5% in the lysate, confirmed by isopropanol stability test and mass spectrometry, demonstrating rapid co-translational or early post-translational degradation.\",\n      \"method\": \"Isopropanol stability test, mass spectrometry of precipitate and lysate fractions\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal biochemical methods establishing the mechanism of instability; single lab\",\n      \"pmids\": [\"28696843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The HBA1 insertion variant Hb Bakersfield [HBA1:c.151_152insGGAGCC, inserting Arg-Ser between α49 and α51] produces a stable haemoglobin with increased oxygen affinity, as demonstrated by oxygen affinity testing and isopropanol stability assay in the heterozygous carrier.\",\n      \"method\": \"HPLC quantification, isopropanol stability test, oxygen affinity testing\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional oxygen affinity measurement but single case, single lab\",\n      \"pmids\": [\"28532286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A novel HBA1 variant Hb G-Waimanalo [A1] [α64(E13)Asp→Asn; HBA1:c.193G>A] was found to have decreased oxygen affinity compared to normal haemoglobin, as shown by direct oxygen dissociation curve analysis.\",\n      \"method\": \"Cation exchange HPLC, DNA sequencing, oxygen affinity measurement (oxygen dissociation curve)\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — direct oxygen affinity measurement; single case report\",\n      \"pmids\": [\"26291968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Homozygosity for Hb Charlieu [α106(G13)Leu→Pro; HBA1:c.320T>C] causes a hyperunstable alpha-globin protein: qPCR confirmed normal αCharlieu mRNA levels, but the protein was undetectable by standard electrophoretic methods in erythrocytes and only detectable by mass spectrometry in erythroid progenitors, indicating the mutation causes post-translational protein instability (likely during RBC maturation). New methylene blue-stained aggregates in reticulocytes suggested that incorporation of αCharlieu destabilizes haemoglobin tetramers.\",\n      \"method\": \"qPCR (mRNA stability), capillary electrophoresis, reverse-phase electrophoresis, isoelectric focusing, mass spectrometry of erythroid progenitors, heat stability test, reticulocyte inclusion body staining\",\n      \"journal\": \"Hemoglobin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods distinguishing mRNA from protein instability, mechanistic insight into degradation during erythroid maturation; single lab\",\n      \"pmids\": [\"31190578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Two novel HBA1 mutations in the 3'UTR (c.*119_120insT and c.*150C>A) cause alpha-thalassaemia; in silico structural modelling predicted disruption of RNA secondary structure, impaired binding of RNA-stabilising proteins HuR and AUF1, altered microRNA (miR-16-5p) binding sites, and interference with polyadenylation signals, collectively resulting in mRNA instability and reduced alpha-globin synthesis.\",\n      \"method\": \"Direct Sanger sequencing, in silico RNA secondary structure prediction, in silico protein–RNA interaction modelling (HuR, AUF1), in silico miRNA binding prediction\",\n      \"journal\": \"Annals of hematology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — purely computational/in silico mechanistic inference; no experimental mRNA stability or binding validation\",\n      \"pmids\": [\"41388082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel HBA1 missense mutation (NM_000558.5:c.85G>C, p.Ala29Pro) designated Hb Tozeur was predicted by in silico structural modelling (Swiss-PdbViewer, DynaMut) to destabilize the alpha-globin protein, reduce thermodynamic stability, and alter flexibility near the heme-binding region, consistent with its clinical presentation as alpha-thalassaemia.\",\n      \"method\": \"In silico pathogenicity prediction (PolyPhen-2, SIFT, MutationTaster), structural homology modelling, DynaMut stability prediction\",\n      \"journal\": \"Annals of hematology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — in silico structural prediction only; no wet-lab validation of protein stability or heme binding\",\n      \"pmids\": [\"40484869\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HBA1-encoded haemoglobin alpha is mechanistically established as an oxygen-binding subunit of the haemoglobin tetramer whose R/T allosteric transitions are structurally defined at atomic resolution; it undergoes nonenzymatic glycosylation at specific lysine residues; its 3'-mRNA polyadenylation depends on the conserved AAUAAA signal; in arterial endothelial cells it localises to the myoendothelial junction where its Fe(3+)/Fe(2+) redox state, controlled by CYB5R3, gates eNOS-derived NO signalling to vascular smooth muscle; and recombinant di-alpha fusions prevent αβ-dimer dissociation, demonstrating the structural basis for renal clearance of free haemoglobin.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HBA1 encodes the alpha-1 globin chain, a subunit of adult hemoglobin that binds heme and assembles into α₂β₂ tetramers to mediate oxygen transport in erythrocytes. Specific amino acid substitutions in HBA1 alter oxygen affinity — increasing it (e.g., Lys127→Gln, insertion at residues 49–50) or decreasing it (e.g., Asp64→Asn) — by perturbing the heme-binding pocket or subunit interface contacts [PMID:28532286, PMID:33478272, PMID:26291968]. Certain missense mutations (e.g., Leu106→Pro) produce α-globin protein that is transcribed normally but degraded post-translationally during erythroid differentiation, causing α-thalassemia through protein instability rather than mRNA loss [PMID:31190578]. HBA1 contributes less α-globin mRNA than its paralog HBA2, so equivalent loss-of-function mutations on HBA1 produce milder α-thalassemia phenotypes [PMID:24826793].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Establishing that disruption of splice-regulatory elements in HBA1 abolishes functional α-globin production demonstrated that canonical RNA processing is essential for HBA1 expression.\",\n      \"evidence\": \"PCR cloning and sequencing of a splice acceptor mutation (IVS2, c.301-2A>T) on HBA1 in a patient with α⁺-thalassemia\",\n      \"pmids\": [\"22738642\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct splicing assay was performed; mechanism inferred from mutation position\", \"Whether residual aberrant transcripts are produced was not assessed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of an HBA1 variant (Asp64→Asn) with decreased oxygen affinity showed that residue 64 in the E helix contributes to oxygen-binding properties of the α-globin chain.\",\n      \"evidence\": \"Oxygen dissociation curve analysis of Hb G-Waimanalo in a single laboratory\",\n      \"pmids\": [\"26291968\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single lab with limited mechanistic detail on how the substitution alters affinity\", \"No structural or mutagenesis follow-up\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A mutation at the HBA1 translation initiation codon (ATG→AAG) causing α⁺-thalassemia established that normal translation initiation is required for HBA1 protein production.\",\n      \"evidence\": \"DNA sequencing and hematological phenotyping of a thalassemia carrier\",\n      \"pmids\": [\"27821014\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in vitro translation assay performed\", \"Whether alternative downstream initiation codons are used was not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Characterization of two distinct HBA1 variants — one hyperunstable (Met32→Ile) and one with increased oxygen affinity (insertion at residues 49–50) — revealed that the B helix and CD corner regions are critical determinants of α-globin stability and oxygen binding, respectively.\",\n      \"evidence\": \"Isopropanol stability tests, mass spectrometry quantification of precipitate fractions, and oxygen affinity measurement\",\n      \"pmids\": [\"28696843\", \"28532286\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No crystal structure of either variant to define precise structural perturbation\", \"Heme-binding and subunit interface effects inferred but not directly measured\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that the Leu106→Pro mutation produces stable mRNA but an undetectable protein in mature erythrocytes — while detectable in progenitors by mass spectrometry — established that α-globin quality control operates post-translationally during erythroid differentiation.\",\n      \"evidence\": \"qPCR for mRNA, capillary electrophoresis, isoelectric focusing, and mass spectrometry of erythrocyte progenitors versus mature red cells in a homozygous patient\",\n      \"pmids\": [\"31190578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific proteolytic pathway responsible for degradation was not identified\", \"Whether chaperone-mediated or proteasomal degradation is involved was not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Comparative phenotyping of equivalent HBA1 versus HBA2 deletions confirmed that HBA1 produces less α-globin transcript than HBA2, explaining the milder clinical impact of HBA1 loss-of-function mutations.\",\n      \"evidence\": \"MLPA, gap-PCR breakpoint mapping, and hematological comparison in Hb H disease patients\",\n      \"pmids\": [\"24826793\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct transcription rate or mRNA quantification assay in this study\", \"Epigenetic or chromatin-level basis for differential expression not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of Hb Waikato (Lys127→Gln) with quantitatively increased oxygen affinity (p50 = 20.8 mmHg) but normal protein stability demonstrated that the H helix modulates oxygen binding independently of chain stability.\",\n      \"evidence\": \"p50 measurement, oxygen dissociation curve, capillary electrophoresis, and isopropanol stability test\",\n      \"pmids\": [\"33478272\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for how position 127 alters oxygen affinity not experimentally determined\", \"Effect on cooperativity (Hill coefficient) not reported\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The proteolytic pathway responsible for degrading unstable α-globin variants during erythropoiesis, the structural basis for oxygen-affinity shifts at multiple helix positions, and the mechanism by which HBA1 achieves lower transcriptional output than HBA2 remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structures of disease-associated HBA1 variants exist in the timeline\", \"Proteolytic quality-control machinery for unstable α-globin not identified\", \"Transcriptional regulatory basis for HBA1 vs HBA2 differential expression not experimentally dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0382551\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"complexes\": [\"Hemoglobin (α₂β₂)\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HBA1 encodes the alpha subunit of the adult hemoglobin tetramer (HbA, α₂β₂), an oxygen-transport hemoprotein whose cooperative ligand binding is governed by allosteric R↔T quaternary transitions defined by atomic-resolution crystal structures of the deoxy (T), oxy (R), and a third stable R2 quaternary state [PMID:1177322, PMID:6644819, PMID:1512262, PMID:16765986]. In the alpha subunit, the distal histidine (HisE7) hydrogen-bonds the O₂ ligand, the iron atom sits near the porphyrin plane in the R-state, and C-terminal Arg141α participates in intersubunit salt bridges that stabilize the T-state; nonenzymatic glycosylation occurs preferentially at Lys16α and other surface lysines, generating HbA1c species [PMID:6644819, PMID:7358733]. Beyond erythrocytes, hemoglobin α is expressed in arterial endothelial cells and enriched at the myoendothelial junction, where its Fe³⁺/Fe²⁺ redox state—regulated by CYB5R3—gates eNOS-derived nitric oxide diffusion to vascular smooth muscle, establishing a non-canonical role in vascular tone regulation [PMID:23123858]. Loss-of-function mutations in HBA1 cause alpha-thalassemia, as demonstrated by chromosomal truncations removing the locus and by hyperunstable variants that undergo post-translational degradation during erythroid maturation [PMID:1975428, PMID:31190578].\",\n  \"teleology\": [\n    {\n      \"year\": 1975,\n      \"claim\": \"The first atomic model of the T-state (deoxy) hemoglobin quaternary structure established how the alpha and beta subunits are arranged in the low-affinity conformation, providing the structural foundation for understanding cooperative oxygen binding.\",\n      \"evidence\": \"X-ray crystallography of human deoxyhemoglobin at 2.5 Å resolution\",\n      \"pmids\": [\"1177322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"R-state (oxy) structure not yet determined at comparable resolution\",\n        \"No structural basis for the T→R transition mechanism\"\n      ]\n    },\n    {\n      \"year\": 1976,\n      \"claim\": \"Identification of the AAUAAA hexanucleotide as the conserved polyadenylation signal in alpha- and beta-globin mRNAs established how the 3' end of HBA1 mRNA is processed, a mechanism later shown to be universal for eukaryotic mRNAs.\",\n      \"evidence\": \"Direct RNA sequencing of purified human and rabbit globin mRNAs\",\n      \"pmids\": [\"822353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Protein factors recognizing AAUAAA not yet identified\",\n        \"Functional consequence of signal disruption on alpha-globin expression not tested\"\n      ]\n    },\n    {\n      \"year\": 1980,\n      \"claim\": \"Mapping nonenzymatic glycosylation to specific lysine residues (preferentially Lys16α) on the alpha chain defined the molecular basis for glycated hemoglobin species (HbA1c), explaining how post-translational modification occurs on HBA1-encoded protein.\",\n      \"evidence\": \"In vitro glycosylation with [¹⁴C]-glucose, peptide mapping, and sequencing\",\n      \"pmids\": [\"7358733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Effect of glycosylation on oxygen affinity or allosteric cooperativity not quantified\",\n        \"In vivo glycosylation kinetics not measured\"\n      ]\n    },\n    {\n      \"year\": 1983,\n      \"claim\": \"The R-state (oxy) crystal structure at 2.1 Å revealed the alpha subunit iron-oxygen geometry, the distal HisE7 hydrogen bond to O₂, and the loss of T-state salt bridges at Arg141α, completing the structural picture of the allosteric mechanism.\",\n      \"evidence\": \"Single-crystal X-ray analysis of human oxyhemoglobin\",\n      \"pmids\": [\"6644819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether additional quaternary intermediates exist between T and R states was unknown\",\n        \"Dynamic pathway of the T→R transition unresolved\"\n      ]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"A chromosome 16p13.3 terminal truncation that deleted the alpha-globin regulatory region demonstrated that the chromosomal context upstream of HBA1 is essential for expression, and linked disruption of this locus to alpha-thalassemia.\",\n      \"evidence\": \"Southern blotting, PFGE, DNA sequencing of breakpoint, and family studies\",\n      \"pmids\": [\"1975428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific cis-regulatory elements required for HBA1 expression not delineated\",\n        \"Mechanism by which telomeric healing stabilized the truncation not fully explored\"\n      ]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Discovery of the R2 quaternary state and engineering of di-alpha hemoglobin answered two long-standing questions: whether additional stable allosteric conformations exist (yes—the R2 state differs at the α1β2 interface), and whether preventing αβ-dimer dissociation could eliminate renal toxicity of cell-free hemoglobin (yes—tandem alpha-globin fusion extended in vivo half-life).\",\n      \"evidence\": \"X-ray crystallography at 1.7 Å (R2 state); recombinant di-alpha Hb expression in E. coli with oxygen affinity and pharmacokinetic validation\",\n      \"pmids\": [\"1512262\", \"1552945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological relevance of R2 state in vivo not demonstrated\",\n        \"Whether additional quaternary intermediates exist beyond R, R2, and T\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Ultra-high-resolution structures (1.25 Å) of oxy-, deoxy-, and CO-hemoglobin resolved subtle differences in distal HisE7 hydrogen-bond geometry between alpha and beta subunits, explaining why HisE7 mutations produce different phenotypes in each chain.\",\n      \"evidence\": \"X-ray crystallography at 1.25 Å for three ligation states\",\n      \"pmids\": [\"16765986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Dynamic motions of HisE7 during ligand entry and exit not captured by crystallography\",\n        \"Contribution of each subunit to overall cooperativity still debated\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that hemoglobin α is expressed in arterial endothelial cells and enriched at the myoendothelial junction—where its redox state controlled by CYB5R3 gates NO diffusion to smooth muscle—established a non-canonical vascular signaling role entirely distinct from erythrocyte oxygen transport.\",\n      \"evidence\": \"Co-immunoprecipitation, subcellular fractionation, immunofluorescence, siRNA/knockout mice, pharmacological inhibition, ex vivo vascular reactivity\",\n      \"pmids\": [\"23123858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism of Hbα targeting to the myoendothelial junction unknown\",\n        \"Whether endothelial Hbα expression is regulated independently of erythroid Hbα\",\n        \"Structural basis for the Hbα–eNOS interaction not defined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Characterization of hyperunstable HBA1 variants (Hb Amsterdam-A1 and others) showed that specific missense mutations cause rapid post-translational degradation of alpha-globin protein despite normal mRNA levels, demonstrating that heme pocket and subunit-interface integrity are critical for alpha-globin proteostatic stability during erythroid maturation.\",\n      \"evidence\": \"Isopropanol stability testing, mass spectrometry of precipitate and lysate fractions, qPCR of mRNA in erythroid progenitors\",\n      \"pmids\": [\"28696843\", \"31190578\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Proteolytic pathway responsible for degradation of hyperunstable alpha-globin not identified\",\n        \"Whether AHSP stabilizes these variants in vivo not tested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Overexpression of HBA1 in AML cells inhibited proliferation and induced apoptosis, raising the possibility of a tumor-suppressive role outside erythroid lineages, though the downstream pathway remains uncharacterized.\",\n      \"evidence\": \"RT-qPCR in patient samples, transfection/overexpression in K562 cells, CCK-8 assay, flow cytometry\",\n      \"pmids\": [\"36117408\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism linking HBA1 expression to apoptosis and G2/M arrest not defined\",\n        \"Not independently replicated in non-K562 AML models\",\n        \"Whether this reflects an oxygen/NO-dependent or novel function is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the molecular basis for Hbα targeting to the myoendothelial junction, whether endothelial and erythroid Hbα transcription is controlled by distinct regulatory programs, and the identity of the proteolytic machinery that degrades hyperunstable alpha-globin variants during erythropoiesis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism of Hbα localization to myoendothelial junctions unknown\",\n        \"Proteolytic pathway for hyperunstable alpha-globin variants unidentified\",\n        \"Non-canonical (non-erythroid) functions of Hbα lack systematic characterization\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [1, 2, 4, 6]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 2, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\n      \"Hemoglobin tetramer (α₂β₂)\"\n    ],\n    \"partners\": [\n      \"HBB\",\n      \"CYB5R3\",\n      \"NOS3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}